| 582 | 10 | 30 |
| 下载次数 | 被引频次 | 阅读次数 |
目的研究自制三七总皂苷鼻用凝胶喷雾剂的生理适应性、家兔给药后体内的药动学过程,及其对心血管疾病的保护作用。方法选用扫描电镜法,考察喷雾剂的鼻纤毛毒性;HPLC法测定三七总皂苷鼻用凝胶喷雾剂家兔鼻腔给药后血样中人参皂苷Rb1、Rg1的浓度,考察药物在体内的动力学过程,并计算药动学参数;建立大鼠急性缺血性心肌梗死模型,考察三七总皂苷鼻用凝胶喷雾剂对心脑血管疾病的保护作用。结果三七总皂苷鼻用凝胶喷雾剂给药后,Rb1、Rg1在家兔体内的过程符合二室模型,其绝对生物利用度比三七总皂苷滴鼻液高,分别为(42.31±7.54)%和(81.06±32.71)%;可大幅减少大鼠左冠状动脉闭塞所致的心肌梗死面积,且呈剂量依赖性,剂量越高,保护作用越强;该喷雾剂基本无明显鼻纤毛毒性。结论药动学、药效学及鼻纤毛毒性试验结果证明,三七总皂苷鼻腔给药制剂具有很好的开发前景。
Abstract:AIM To prepare a nasal spray with gelling agent for intranasal delivery of Panax notoginseng saponins( PNS),to investigate its absorption rate and pharmacokinetic profile with different routes of administration and formulations,and to evaluate its efficacy on a myocardial infarction model in rabbits. METHODS The ciliotoxicity from the gel were investigated. Concentration of Rb1 or Rg1 was determined using a simple HPLC method.The pharmacokinetic parameters and cardio-protective effect against myocardial infarction of the gel were investigated. RESULTS The in vivo course of Rb1 or Rg1 in rabbits conformed to two-compartment model after intranasal administration of PNS gel and the absolute bioavailability was higher than that of PNS intranasal solution[( 42. 31 ±7. 54) % vs( 81. 06 ± 32. 71) %]. The gel significantly reduced myocardial infarct size induced by occlusion of the left coronary artery. And the effects were dose-dependent,the higher dose,the better effects. The spray was no obvious ciliotoxicity. CONCLUSION PNS nasal spray with gelling agent may be a promising approach for the intranasal delivery of PNS for prolongation of drug delivery and improvement of systemic Rb1 and Rg1 absorption,thus enhancing its bioavailability and cardio-protective effect.
[1]Han SY,Li HX,Ma X,et al.Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats[J].J Ethnopharmacol,2013,145(3):722.
[2]Zeng XS,Zhou XS,Luo FC,et al.Comparative analysis of the neuroprotective effects of ginsenosides Rg1 and Rb1 extracted from Panax notoginseng against cerebral ischemia[J].Can J Physiol Pharmacol,2014,92(2):102.
[3]王晓燕,张腾.浅谈三七及其制剂在心脑血管疾病之异病同治[J].医学综述,2013,19(6):1086.
[4]Yang X,Xiong X,Wang J.Sanqi panax notoginseng injection for angina pectoris[J].Evid Based Complement Alternat Med,http://dx.doi.org/10.1155/2014/963208.
[5]韩旻,韩丽妹,王青松,等.三七皂苷的口服吸收机制[J].药学学报,2006,41(6):498.
[6]Fortuna A,Alves G,Serralheiro A,et al.Intranasal delivery of systemic-acting drugs:Small-molecules and biomacromolecules[J].Eur J Pharm Biopharm,2014,pii:S0939-6411(14)00081-2.
[7]Costantino HR,Illum L,Brandt G,et al.Intranasal delivery:physicochemical and therapeutic aspects[J].Int J Pharm,2007,337(1-2):1.
[8]Qian S,Wong YC,Zuo Z.Development,characterization and application of in situ gel systems for intranasal delivery of tacrine[J].Int J Pharm,2014,468(1-2):272.
[9]Costantino HR,Illum L,Brandt G,et al.Intranasal delivery:physicochemical and therapeutic aspects[J].Int J Pharm,2007,337(1-2):1.
[10]吴云娟,朱晓艺,沙先谊,等.三七总皂苷鼻腔给药的药代动力学与药效学[J].药学学报,2005,40(4):336.
[11]许清芳,方晓玲,陈道峰,等.三七总皂苷鼻腔用制剂的研究[J].药学学报,2003,38(11):859.
[12]罗洁琦,沙先谊,方晓玲.三七总皂苷离子敏感型鼻用原位凝胶的制备[J].中草药,2011,42(7):1299.
[13]冯程程,刘青锋,邵夏炎,等.碱性成纤维生长因子鼻腔喷雾剂的质量评价[J].中国医院药学杂志,2012,32(9):671.
[14]张俊义,王正忠,戴红艳,等.大鼠心肌梗死模型制作方法探讨[J].青岛大学医学院学报,2013,49(2):121.
[15]莫镇涛,方永奇.鼻腔给药的优势及影响因素[J].今日药学,2010,20(7):1.
[16]Bhardwaj A,Sharma MK,Gupta M.Endoscopic evaluation of therapeutic effects of“Anuloma-Viloma Pranayama"in Pratishyaya w.s.r.to mucociliary clearance mechanism and Bernoulli's principle[J].Ayu,2013,34(4):361.
[17]邱湘龙,李振华,朱兴一,等.药用辅料羟丙基纤维素在制剂中的应用[J].中国现代应用药学杂志,2007,24(8):693.
基本信息:
DOI:10.19577/j.cnki.issn10074406.2014.05.003
中图分类号:R285.5
引用信息:
[1]邓春丽,罗洁琦,沙先谊,等.三七总皂苷鼻用凝胶喷雾剂的药动学与药效学研究[J].中国临床药学杂志,2014,23(05):276-282.DOI:10.19577/j.cnki.issn10074406.2014.05.003.
基金信息:
国家重大科技专项经费资助项目(编号2009ZX09310-006); 上海市科学技术委员会科研计划项目(编号10DZ1972400)
2014-09-25
2014-09-25